ArticleEuropean journal of clinical pharmacology2019

Pharmacokinetics and safety of glecaprevir and pibrentasvir in HCV-negative subjects with hepatic impairment.

Matthew P Kosloski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.